Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Mortality outcome, ALT level | No. of death, n (%) | Unadjusted | Age-adjusted | Multivariate-adjusted | |||
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | ||
All-cause | |||||||
< 0.5 ULN | 306 (61.1) | 1 | 1 | 1 | |||
0.5-1 ULN | 436 (45.2) | 0.60 (0.52-0.70) | < 0.001 | 0.69 (0.59-0.80) | < 0.001 | 0.68 (0.58-0.80) | < 0001 |
1-2 ULN | 115 (30.8)) | 0.37 (0.30-0.46) | < 0.001 | 0.62 (0.50-0.77) | < 0.001 | 0.60 (0.47-0.76) | < 0001 |
≥ 2 ULN | 21 (22.6) | 0.26 (0.16-0.40) | < 0.001 | 0.69 (0.44-1.09) | 0.11 | 0.72 (0.42-1.21) | 0.214 |
Cardiovascular disease | |||||||
< 0.5 ULN | 102 (20.4) | 1 | 1 | 1 | |||
0.5-1 ULN | 119 (22.3) | 0.50 (0.39-0.65) | < 0.001 | 0.58 (0.44-0.76) | < 0.001 | 0.57 (0.43-0.77) | < 0.001 |
1-2 ULN | 34 (9.1) | 0.34 (0.23-0.50) | < 0.001 | 0.58 (0.39-0.87) | 0.007 | 0.55 (0.33-0.92) | 0.022 |
≥ 2 ULN | 3 (3.2) | 0.11 (0.04-0.36) | < 0.001 | 0.33 (0.10-1.05) | 0.06 | 0.51 (0.13-1.97) | 0.331 |
Cancer | |||||||
< 0.5 ULN | 67 (13.4) | 1 | 1 | 1 | |||
0.5-1 ULN | 103 (10.7) | 0.65 (0.48-0.89) | 0.006 | 0.73 (0.54-1.00) | 0.051 | 0.79 (0.57-1.10) | 0.169 |
1-2 ULN | 25 (6.7) | 0.37 (0.23-0.58) | < 0.001 | 0.62 (0.39-0.99) | 0.047 | 0.76 (0.45-1.29) | 0.308 |
≥ 2 ULN | 5 (5.4) | 0.28 (0.11-0.69) | 0.006 | 0.81 (0.32-2.05) | 0.654 | 1.05 (0.35-3.12) | 0.935 |
Others | |||||||
< 0.5 ULN | 137 (44.8) | 1 | 1 | 1 | |||
0.5-1 ULN | 214 (49.1) | 0.81 (0.65-1.00) | 0.048 | 0.81 (0.66-1.01) | 0.058 | 0.73 (0.57-0.92) | 0.921 |
1-2 ULN | 56 (48.7) | 0.68 (0.50-0.92) | 0.014 | 0.75 (0.55-1.03) | 0.073 | 0.57 (0.38-0.85) | 0.851 |
≥ 2 ULN | 13 (61.9) | 0.70 (0.39-1.23) | 0.212 | 0.76 (0.42-1.37) | 0.361 | 0.40 (0.19-0.84) | 0.844 |
- Citation: Zheng JR, Wang ZL, Jiang SZ, Chen HS, Feng B. Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World J Hepatol 2023; 15(6): 813-825
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/813.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.813